Gilead Sciences, Inc. v. Sigmapharm Labs

U.S. Court of Appeals for the Federal Circuit

Gilead Sciences, Inc. v. Sigmapharm Labs

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

GILEAD SCIENCES, INC., Plaintiff-Appellee,

v.

SIGMAPHARM LABORATORIES, LLC, Defendant-Appellant. ______________________

2014-1456 ______________________

Appeal from the United States District Court for the District of New Jersey in No. 2:10-cv-04931-SDW-MCA, Judge Susan D. Wigenton. ______________________

JUDGMENT ______________________

TIMOTHY J. KELLY, Fitzpatrick, Cella, Harper & Scin- to, of New York, New York, argued for plaintiff-appellee. With him on the brief was CHRISTOPHER E. LOH. Of counsel was COLLEEN TRACY.

JOHN E. ROSENQUIST, Leydig, Voit & Mayer, LTD., of Chicago, Illinois, argued for defendant-appellant. With him on the brief was MARC R. WEZOWSKI. Of counsel on the brief were K. LEE MARSHALL and ROBERT L. STOLEBARGER, Bryan Cave LLP, of San Francisco, Cali- fornia; and AMEER GADO and ANTHONY FRIEDMAN, of St. Louis, Missouri. Of counsel was KAREN A. CONFOY, Fox Rothschild, of Lawrenceville, New Jersey. ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (DYK, REYNA, and HUGHES, Circuit Judg- es). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

December 8, 2014 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court

Reference

Status
Unpublished